• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球范围内以家庭为基础的根除策略,以预防其相关疾病和胃癌。

Global whole family based- eradication strategy to prevent its related diseases and gastric cancer.

机构信息

Department of Gastroenterology and Hepatology, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, and Henan University School of Medicine, Zhengzhou 450003, Henan Province, China.

出版信息

World J Gastroenterol. 2020 Mar 14;26(10):995-1004. doi: 10.3748/wjg.v26.i10.995.

DOI:10.3748/wjg.v26.i10.995
PMID:32205991
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7080999/
Abstract

() infects approximately 50% of the world population. The multiple gastrointestinal and extra-gastrointestinal diseases caused by infection pose a major healthcare threat to families and societies; it is also a heavy economic and healthcare burden for countries that having high infection rates. Eradication of is recommended for all infected individuals. Traditionally, "test and treat" and "screen and treat" strategies are available for various infected populations. However, clinical practice has noticed that these strategies have some shortfalls and may need refinement, mostly due to the fact that they are not easily manageable, and are affected by patient compliance, selection of treatment population and cost-benefit estimations. Furthermore, it is difficult to control infections from the source, therefore, development of additional, compensative strategies are encouraged to solve the above problems and facilitate bacteria eradication. infection is a family-based disease, but few studies have been performed in a whole family-based approach to curb its intra-familial transmission and the development of related diseases. In this work, a third, novel whole family-based eradication strategy is introduced. This approach screens, identifies, treats and follows up on all -infected individuals in entire families to control infection among family members, and reduce its long-term complications. This strategy is high-risk population-oriented, and able to reduce spread among family members. It also has good patient-family compliance and, importantly, is practical for both high and low -infected communities. Future efforts in these areas will be critical to initiate and establish healthcare policies and management strategies to reduce -induced disease burden for society.

摘要

感染了世界上大约 50%的人口。感染引起的多种胃肠道和胃肠道外疾病对家庭和社会构成了重大的医疗保健威胁;对于感染率高的国家来说,它也是一个沉重的经济和医疗保健负担。建议对所有感染个体进行根除。传统上,有“检测和治疗”和“筛查和治疗”策略可用于各种感染人群。然而,临床实践注意到这些策略存在一些缺陷,可能需要改进,主要是因为它们不容易管理,并且受到患者依从性、治疗人群选择和成本效益评估的影响。此外,从源头控制感染很困难,因此,鼓励开发额外的补偿性策略来解决上述问题并促进细菌根除。感染是一种基于家庭的疾病,但很少有研究采用全家庭方法来遏制其家庭内传播和相关疾病的发展。在这项工作中,引入了第三种新的全家庭根除策略。该方法对所有感染个体进行筛查、识别、治疗和随访,以控制家庭成员中的感染,并减少其长期并发症。该策略以高危人群为导向,能够减少家庭成员之间的传播。它还具有良好的患者-家庭依从性,重要的是,对于高感染和低感染社区都实用。在这些领域的未来努力对于启动和建立医疗保健政策和管理策略以减轻社会因感染引起的疾病负担至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3128/7080999/14da879d6f61/WJG-26-995-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3128/7080999/14da879d6f61/WJG-26-995-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3128/7080999/14da879d6f61/WJG-26-995-g001.jpg

相似文献

1
Global whole family based- eradication strategy to prevent its related diseases and gastric cancer.全球范围内以家庭为基础的根除策略,以预防其相关疾病和胃癌。
World J Gastroenterol. 2020 Mar 14;26(10):995-1004. doi: 10.3748/wjg.v26.i10.995.
2
Family-based Helicobacter pylori infection control and management strategy and screen-and-treat strategy are highly cost-effective in preventing multiple upper gastrointestinal diseases in Chinese population at national level.在国家层面上,基于家庭的幽门螺杆菌感染防控和管理策略以及筛查和治疗策略在预防中国人群多种上消化道疾病方面具有很高的成本效益。
Helicobacter. 2024 May-Jun;29(3):e13063. doi: 10.1111/hel.13063.
3
Chinese Consensus Report on Family-Based Infection Control and Management (2021 Edition).中国家族性感染防控与管理专家共识(2021 年版)
Gut. 2022 Feb;71(2):238-253. doi: 10.1136/gutjnl-2021-325630. Epub 2021 Nov 26.
4
The effect of eradication of Helicobacter pylori on gastric cancer prevention in healthy asymptomatic populations.根除幽门螺杆菌对健康无症状人群胃癌预防的影响。
Helicobacter. 2018 Apr;23(2):e12464. doi: 10.1111/hel.12464. Epub 2018 Jan 18.
5
Strategies for Prevention of Gastric Cancer: Progress from Mass Eradication Trials.胃癌预防策略:大规模根除试验的进展
Dig Dis. 2016;34(5):500-4. doi: 10.1159/000445229. Epub 2016 Jun 22.
6
Both family-based Helicobacter pylori infection control and management strategy and screen-and-treat strategy are cost-effective for gastric cancer prevention.基于家庭的幽门螺杆菌感染防控和管理策略以及筛查和治疗策略对于预防胃癌都是具有成本效益的。
Helicobacter. 2022 Aug;27(4):e12911. doi: 10.1111/hel.12911. Epub 2022 Jun 15.
7
[Croatian guidelines for gastric cancer prevention by eradication of Helicobacter pylori infection].[克罗地亚根除幽门螺杆菌感染预防胃癌指南]
Lijec Vjesn. 2014 Mar-Apr;136(3-4):59-68.
8
Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer.基于人群的幽门螺杆菌筛查预防胃癌的临床和经济效果
Arch Intern Med. 1999 Jan 25;159(2):142-8. doi: 10.1001/archinte.159.2.142.
9
[Gastrointestinal manifestations of Helicobacter pylori infection in adults: from gastritis to gastric cancer].[成人幽门螺杆菌感染的胃肠道表现:从胃炎到胃癌]
Presse Med. 2008 Mar;37(3 Pt 2):519-24. doi: 10.1016/j.lpm.2007.07.031. Epub 2008 Feb 7.
10
Helicobacter pylori eradication as a preventive tool against gastric cancer.根除幽门螺杆菌作为预防胃癌的一种手段。
Asian Pac J Cancer Prev. 2004 Jul-Sep;5(3):246-52.

引用本文的文献

1
Prevalence and risk factors of infection in urban children aged 6-13 years in Fuzhou, China: a cross-sectional study in a high gastric cancer incidence region.中国福州6-13岁城市儿童感染的患病率及危险因素:一项在胃癌高发地区的横断面研究
Front Pediatr. 2025 Jul 16;13:1457195. doi: 10.3389/fped.2025.1457195. eCollection 2025.
2
Managing : elimination challenges.管理:消除挑战。
Therap Adv Gastroenterol. 2025 Apr 29;18:17562848251336293. doi: 10.1177/17562848251336293. eCollection 2025.
3
The epidemiological study of family-based Helicobacter pylori screening and its benefits: a cross-sectional study.

本文引用的文献

1
[Focusing on whole family based- infection management and clinical research to prevent gastric mucosal diseases and gastric cancer].聚焦基于全家庭的感染管理与临床研究以预防胃黏膜疾病和胃癌
Zhonghua Yi Xue Za Zhi. 2019 May 21;99(19):1446-1448. doi: 10.3760/cma.j.issn.0376-2491.2019.19.003.
2
Classification of Helicobacter pylori Virulence Factors: Is CagA a Toxin or Not?幽门螺杆菌毒力因子的分类:CagA 是毒素吗?
Trends Microbiol. 2019 Sep;27(9):731-738. doi: 10.1016/j.tim.2019.04.010. Epub 2019 May 23.
3
Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition.
基于家庭的幽门螺杆菌筛查的流行病学研究及其益处:一项横断面研究。
Sci Rep. 2025 Feb 14;15(1):5553. doi: 10.1038/s41598-025-87836-5.
4
eradication for primary prevention of gastric cancer: progresses and challenges.胃癌一级预防中的根除治疗:进展与挑战
J Natl Cancer Cent. 2024 Jul 20;4(4):299-310. doi: 10.1016/j.jncc.2024.06.006. eCollection 2024 Dec.
5
Liposomal Drug Delivery against Using Furazolidone and N-Acetyl Cysteine in Augmented Therapy.在强化治疗中使用呋喃唑酮和N-乙酰半胱氨酸的脂质体药物递送。 (注:原文against后内容缺失,翻译可能存在一定局限性)
Pharmaceutics. 2024 Aug 26;16(9):1123. doi: 10.3390/pharmaceutics16091123.
6
Nisin Inhibition of Gram-Negative Bacteria.乳酸链球菌素对革兰氏阴性菌的抑制作用。
Microorganisms. 2024 Jun 19;12(6):1230. doi: 10.3390/microorganisms12061230.
7
Total worker health based public health prevention strategy.基于劳动者全面健康的公共卫生预防策略。
Curr Opin Epidemiol Public Health. 2024 May 28;3(2):33-39. doi: 10.1097/PXH.0000000000000035. eCollection 2024 Jun.
8
Antibiotic resistance in Helicobacter pylori among children and adolescents in East Asia: A systematic review and meta-analysis.东亚儿童和青少年中幽门螺杆菌的抗生素耐药性:系统评价和荟萃分析。
Chin Med J (Engl). 2024 Aug 20;137(16):1926-1938. doi: 10.1097/CM9.0000000000002884. Epub 2024 Jan 16.
9
Evolving Concepts in Helicobacter pylori Management.幽门螺杆菌管理中不断发展的概念。
Gastroenterology. 2024 Feb;166(2):267-283. doi: 10.1053/j.gastro.2023.09.047. Epub 2023 Oct 6.
10
Bacteria in cancer initiation, promotion and progression.癌症起始、促进和进展中的细菌。
Nat Rev Cancer. 2023 Sep;23(9):600-618. doi: 10.1038/s41568-023-00594-2. Epub 2023 Jul 3.
日本幽门螺杆菌感染管理指南:2016 年修订版。
Helicobacter. 2019 Aug;24(4):e12597. doi: 10.1111/hel.12597. Epub 2019 May 20.
4
Helicobacter pylori Infection in Children and Adolescents.儿童和青少年幽门螺杆菌感染。
Adv Exp Med Biol. 2019;1149:107-120. doi: 10.1007/5584_2019_361.
5
Where are we today with infection among healthy children in Saudi Arabia?目前沙特阿拉伯健康儿童的感染情况如何?
Saudi J Gastroenterol. 2019 Sep-Oct;25(5):309-318. doi: 10.4103/sjg.SJG_531_18.
6
Recurrence of Helicobacter pylori infection: incidence and influential factors.幽门螺杆菌感染的复发:发生率及影响因素。
Chin Med J (Engl). 2019 Apr 5;132(7):765-771. doi: 10.1097/CM9.0000000000000146.
7
How far are we from vaccination against Helicobacter pylori infection?我们离预防幽门螺杆菌感染的疫苗还有多远?
Expert Rev Vaccines. 2018 Oct;17(10):935-945. doi: 10.1080/14760584.2018.1526680. Epub 2018 Sep 26.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
: A foodborne pathogen?: 食源性致病菌?
World J Gastroenterol. 2018 Aug 21;24(31):3472-3487. doi: 10.3748/wjg.v24.i31.3472.
10
eradication in the treatment of gastric hyperplastic polyps: beyond National Health Insurance.胃增生性息肉治疗中的根除治疗:超出国民健康保险范畴
Korean J Intern Med. 2018 May;33(3):490-492. doi: 10.3904/kjim.2018.122. Epub 2018 May 1.